Wakefield Clinical Research
Wakefield Clinical Research
  • Home
  • Who We Work With
  • Early-Phase & PK Study
  • Medical Device/IVD Trials
  • Consulting Services
  • Clinical Operation
  • Regulatory Affairs
  • Quality Assurance
  • Clinical Research Site
  • Our Team
  • Enrolling Studies
  • Therapeutic Expertise
  • Contact

Sponsors We Support

We partner with innovators developing new therapies and medical technologies, including:

• Emerging biotechnology companies
• Small and mid-size pharmaceutical sponsors
• Medical device innovators
• Academic investigators developing novel therapeutics
• Early-stage companies preparing for IND or first-in-human studies
• Global sponsors seeking experienced U.S. clinical trial execution

What Makes Wakefield a Strong Partner

We provide a flexible CRO + clinical site model to support early-phase and specialty clinical trials

 We work closely with sponsors who value: 

• Efficient study startup
• Direct communication with experienced clinical teams
• Flexible operational support
• Cost-effective study execution
• Strong regulatory strategy and IND support 

Studies We Support

Wakefield Clinical Research supports a wide range of clinical development programs, including:

 • Early-phase clinical studies
• Drug-drug interaction (DDI) studies
• Phase I patient studies
• Pharmacokinetic (PK) studies
• Specialty clinical trials requiring intensive sampling
• First-in-human and proof-of-concept trials 

Flexible Engagement Models

Wakefield Clinical Research can support sponsors through multiple engagement models:

 • Full-service CRO support
• CRO services combined with our clinical research site
• Site-only participation in multicenter studies
• Strategic consulting for early development programs  

Ideal Partners

Wakefield Clinical Research is particularly well suited for sponsors who:

 • Need hands-on operational support
• Are running early-phase or specialty clinical trials
• Prefer working with a nimble CRO partner
• Value direct access to experienced clinical leadership   

Our Typical Sponsor Profile

 • Seed-stage biotech preparing IND
• Series A/B biotech developing first clinical asset
• Small pharma expanding indications
• Device companies conducting early feasibility studies  

Copyright © 2026 Wakefield Clinical Research - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept